Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention

J Invasive Cardiol. 2000 Dec:12 Suppl F:14F-9.

Authors

K R Campbell¹, K W Mahaffey, B E Lewis, J I Weitz, S D Berkowitz, E M Ohman, R M Califf

Affiliation

¹ Duke Clinical Research Institute, P.O. Box 17969, Durham, NC 27715, USA.

PMID: 11156729

No abstract available

Publication types

Review

MeSH terms

Angina Pectoris / therapy
Angioplasty, Balloon, Coronary* / adverse effects
Angioplasty, Balloon, Coronary* / methods
Anticoagulants / adverse effects*
Antithrombins / therapeutic use*
Coronary Thrombosis / etiology
Coronary Thrombosis / prevention & control
Heparin / adverse effects*
Hirudin Therapy*
Hirudins / analogs & derivatives*
Humans
Peptide Fragments / therapeutic use*
Recombinant Proteins / therapeutic use*
Safety
Thrombocytopenia / chemically induced*
Thrombocytopenia / drug therapy
Treatment Outcome

Substances

Anticoagulants
Antithrombins
Hirudins
Peptide Fragments
Recombinant Proteins
Heparin
bivalirudin